Shahram Salek-Ardakani
Plus aucun poste en cours
Provenance du réseau au premier degré de Shahram Salek-Ardakani
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shahram Salek-Ardakani via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| Stanford University | College/University | Graduate Degree Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin | |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ATP Capital LP
 ATP Capital LP Real Estate DevelopmentFinance ATP Capital LP provides real estate investment and management services. The company was founded by Jonathan R. Malkin in 1997 and is headquartered in Clearwater Beach, FL. | Real Estate Development | Corporate Officer/Principal | |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Otto Eckart GmbH
 Otto Eckart GmbH Other Consumer ServicesConsumer Services Otto Eckart GmbH operates museums. The private company is based in Munich, Germany. The German company was founded in 1996 by Otto Eckart. The CEO is Martin Schütze. | Other Consumer Services | Director/Board Member | |
| University of San Francisco | College/University | Undergraduate Degree | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Santa Barbara & Ventura Colleges of Law | College/University | Graduate Degree | |
| University of New England | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
| Institute For Stem Cell Biology & Regenerative Medicine | Corporate Officer/Principal | ||
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal | |
Medikine, Inc.
 Medikine, Inc. Pharmaceuticals: MajorHealth Technology Medikine, Inc. is a privately held biopharmaceutical company located in an undisclosed location. The American company's mission is to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular "peptikines." These peptikines are peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Medikine's lead candidate, mdk-703, is currently in a phase 1 clinical trial in healthy volunteers. Ronald W. Barrett has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer | |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 43 |
| Allemagne | 4 |
| Royaume-Uni | 3 |
| Canada | 2 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 8 |
| Finance | 5 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 40 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 18 |
| Founder | 9 |
| Director of Finance/CFO | 8 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Alana McNulty | 12 |
| Winston Kung | 12 |
| Ronald Barrett | 9 |
| Wayne Godfrey | 9 |
| Stefan Heller | 9 |
| Byron Robinson | 7 |
| Brenda Van Vreeswyk | 4 |
- Bourse
- Insiders
- Shahram Salek-Ardakani
- Connexions Sociétés